I refer to our recent telephone discussion.
Alchemia Limited (ACL) requests that a trading halt be granted by the Australian Securities Exchange with respect to its ordinary shares immediately.
In accordance with Listing Rule 17.1, I advise that:
ACL is seeking the trading halt pending the release of an announcement by ACL regarding its profit share on sales of its generic anti-coagulant drug fondaparinux for the quarter ending 31 March 2015;
ACL requests that the trading halt last until the commencement of trading on Tuesday, 26 May 2015 (unless ACL requests that it be removed earlier); and
ACL is not aware of any reason why the trading halt should not be granted.
- Forums
- ASX - By Stock
- TSN
- Ann: Response to ASX Price Query
Ann: Response to ASX Price Query, page-2
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add TSN (ASX) to my watchlist
(20min delay)
|
|||||
Last
1.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.409M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
TSN (ASX) Chart |
Day chart unavailable
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non--Executive Director
Simon Kidston
Non--Executive Director
SPONSORED BY The Market Online